PRESS RELEASE published on 10/22/2025 at 13:30, 6 months 27 days ago Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin Medicus Pharma enrolls first patient in SKNJCT-004 phase 2 clinical study for non-invasive BCC treatment in UAE with Cleveland Clinic Abu Dhabi as lead investigator Clinical Study Medicus Pharma SKNJCT-004 BCC Treatment Cleveland Clinic Abu Dhabi
BRIEF published on 10/13/2025 at 13:35, 7 months 5 days ago Medicus Pharma Ltd. présentera au Maxim Growth Summit 2025 Conférence Sur Les Biotechnologies Medicus Pharma Teverelix Sommet Maxim Growth Injection Cutanée
BRIEF published on 10/13/2025 at 13:35, 7 months 5 days ago Medicus Pharma Ltd. to Present at Maxim Growth Summit 2025 Biotech Conference Medicus Pharma Teverelix Maxim Growth Summit Skinject
PRESS RELEASE published on 10/13/2025 at 13:30, 7 months 5 days ago Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025 Medicus Pharma Ltd. CEO to join fireside chat at Maxim Growth Summit, discussing clinical development programs of Skinject (skin diseases) and Teverelix (advanced prostate cancer) Clinical Development Fireside Chat CEO Medicus Pharma Ltd. Maxim Growth Summit
BRIEF published on 10/07/2025 at 13:35, 7 months 11 days ago Medicus Pharma participera au sommet des family offices de Dubaï Développement Clinique Intelligence Artificielle Innovations Biotechnologiques Medicus Pharma Sommet Des Family Offices
BRIEF published on 10/07/2025 at 13:35, 7 months 11 days ago Medicus Pharma to Participate in Dubai Family Office Summit Artificial Intelligence Clinical Development Biotech Innovations Medicus Pharma Family Office Summit
PRESS RELEASE published on 10/07/2025 at 13:30, 7 months 11 days ago Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE Dr. Raza Bokhari, Executive Chairman & CEO of Medicus, to discuss biotech innovation and wealth transfer at Family Office Summit in Dubai Biotech Innovation Family Office Summit Medicus Raza Bokhari Wealth Transfer
BRIEF published on 09/29/2025 at 13:35, 7 months 19 days ago Medicus Pharma Ltd. obtient le soutien de la FDA pour le développement de Skinject Essais Cliniques Approbation De La FDA Medicus Pharma Carcinome Basocellulaire Développement De Skinject
BRIEF published on 09/29/2025 at 13:35, 7 months 19 days ago Medicus Pharma Ltd. Gains FDA Support for Skinject Development FDA Approval Clinical Trials Medicus Pharma Basal Cell Carcinoma Skinject Development
PRESS RELEASE published on 09/29/2025 at 13:30, 7 months 19 days ago Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject FDA agrees to 505(b)(2) pathway for Medicus Pharma's Skinject D-MNA to treat BCC, positive Type C meeting feedback, SKNJCT-003 patient recruitment aims, EOP2 request in Q1 2026 FDA Clinical Study Medicus Pharma Skinject D-MNA BCC
Published on 05/18/2026 at 14:37, 3 hours 22 minutes ago Tyson Fury, The Gypsy King, Joins Datavault AI as International Spokesperson to Champion Athlete Data Monetization
Published on 05/18/2026 at 14:30, 3 hours 29 minutes ago Ebola Global Health Emergency Needs a Broad-Spectrum Drug - NV-387 is a Strong Potential Candidate, Says NanoViricides
Published on 05/16/2026 at 01:15, 2 days 16 hours ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/18/2026 at 17:37, 22 minutes ago Turkiye Garanti Bankasi A.S.: Bond, subordinated debts, that can be included in the equity calculation debt instrument issuance CMB Application
Published on 05/18/2026 at 17:36, 22 minutes ago GEVELOT S.A.: Déclaration hebdomadaire de rachat d'actions 18 05 2026
Published on 05/18/2026 at 17:36, 22 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 05/18/2026 (French only)
Published on 05/18/2026 at 17:19, 39 minutes ago Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy
Published on 05/18/2026 at 17:43, 16 minutes ago Aéroports de Paris S.A - Trafic du mois d'avril 2026
Published on 05/18/2026 at 17:41, 17 minutes ago Reporting on share buyback transactions carried out between May 13 and May 15, 2026